Open Access
CC BY 4.0 · VCOT Open 2025; 08(01): e46-e55
DOI: 10.1055/a-2535-5731
Clinical Communication

Factors Affecting the Candidacy for Total Hip Replacement Assessed in 953 Dogs

1   Department of Veterinary Clinical Sciences, Ohio State University, Columbus, Ohio, United States
,
Christina E. Orona
1   Department of Veterinary Clinical Sciences, Ohio State University, Columbus, Ohio, United States
,
Elizabeth M. Parker
2   Department of Veterinary Preventive Medicine, Ohio State University, Columbus, Ohio, United States
,
Jonathan Dyce
1   Department of Veterinary Clinical Sciences, Ohio State University, Columbus, Ohio, United States
› Institutsangaben

Funding This work received support for statistical analysis from the Glass family.
Preview

Abstract

To define reasons for delay to canine total hip replacement (THR). Retrospective clinical study of 953 dogs evaluated for THR between 2013 and 2020. Three hundred and fifty-three dogs (37%) proceeded to immediate THR. Reasons for the initial delay in 600 dogs (63%) included: medical management (42%), other orthopaedic conditions (25%), pyoderma (12%), neurologic disease (7%), concurrent medical condition (7%), immature age (3%), prohibitive behaviour (3%), and for lack of advanced imaging requirement (1%). Of the 92% of dogs with hip dysplasia/osteoarthritis (HD/OA), 32% proceeded to THR without delay. One-hundred and thirteen (19%) dogs that were rejected initially, subsequently had THR. The highest percentage returning for THR were those initially rejected for pyoderma (74%), advanced imaging (67%), and skeletal immaturity (35%). The lowest percentage for THR return included concurrent orthopaedic conditions (3%), neurologic disease (1%), and prohibitive behaviour (0%). The most common reason for referral for evaluation for a THR was OA. The majority of dogs were rejected because of incomplete medical management. Immediate THR following primary evaluation is uncommon and common reasons for delay are incomplete medical management, incorrect initial diagnosis, and prohibitive comorbidities.

Authors' Contributions

A.K.E.: substantial contribution to conception and study design, acquisition, analysis, interpretation of data, drafting and revision of work, and final approval of version to be published.


C.E.O: substantial contribution to data collection, drafting and revision of work, and final approval of version to be published.


E.M.P.: substantial contribution to data analysis, drafting and revision of work, and final approval of version to be published.


J.D.: substantial contribution to conception and study design, acquisition, analysis, interpretation of data, drafting and revision of work, and final approval of version to be published.




Publikationsverlauf

Eingereicht: 11. Oktober 2024

Angenommen: 05. Februar 2025

Artikel online veröffentlicht:
26. März 2025

© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany